Translocator protein (TSPO 18 kDa) is expressed by neural stem and neuronal precursor cells

Neuroscience Letters

Volumn 462, Issue 3, 2009, Pages 257-262

  Varga, Balázs ^a   Markó, Károly ^a   Hádinger, Nóra ^a   Jelitai, Márta ^a   Demeter, Kornél ^a   Tihanyi, Károly ^b   Vas, Ádám ^b   Madarász, Emília ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b GEDEON RICHTER LTD   (Hungary)

Author keywords

Neuronal differentiation; Peripheral benzodiazepine binding; Translocator protein (18 kDa)

Indexed keywords

BENZODIAZEPINE RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN DAMAGE; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; MOUSE; NERVE CELL DIFFERENTIATION; NERVE REGENERATION; NEURAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYO, MAMMALIAN; MICE; NEURAL PLATE; NEURONS; RECEPTORS, GABA; RNA, MESSENGER; STEM CELLS;

EID: 68049086619     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.06.051     Document Type: Article

References (30)

1. Baulieu E.E. Neurosteroids: a new function in the brain. Biol. Cell 71 (1991) 3-10
2. Benavides J., Cornu P., Dennis T., Dubois A., Hauw J.J., MacKenzie E.T., Sazdovitch V., and Scatton B. Imaging of human brain lesions with an omega 3 site radioligand. Ann. Neurol. 24 (1988) 708-712
3. Casellas P., Galiegue S., and Basile A.S. Peripheral benzodiazepine receptors and mitochondrial function. Neurochem. Int. 40 (2002) 475-486
4. Fiskum G., Chandrasekaran K., Bambrick L.L., and Krueger B.K. Cyclosporin A protects astrocyte but not cerebellar granule neuron mitochondria from calcium induced injury. Meet. Am. Anesthesiologists (2005) (Abstr. A-692)
5. Gabryel B., Adamek M., Pudelko A., Malecki A., and Trzeciak H.I. Piracetam and vinpocetine exert cytoprotective activity and prevent apoptosis of astrocytes in vitro in hypoxia and reoxygenation. Neuro. Tox. 23 (2002) 19-31
6. Gulyas B., Halldin C., Vas A., Banati R., Shchukin E., Finnema S., Tarkainen J., Tihanyi K., Szilagyi G., and Farde L. [11C]Vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies. J. Neurol. Sci. 229-230 (2005) 219-223
7. Hirsch T., Decaudin I.-D., Susin S.A., Marchetti P., Larochette N., Resche-Rigon M., and Kroemer G. PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp. Cell Res. 241 (1998) 426-434
8. Jayakumar A.R., Panickar K.S., and Norenberg M.D. Effects on free radical generation by ligands of the peripheral benzodiazepine receptor in cultured neural cells. J. Neurochem. 83 (2002) 1226-1234
9. Jelitai M., Anděrová M., Markó K., Kékesi K., Koncz P., Syková E., and Madarász E. Role of GABA in early neuronal development: studies on an embryonic neuroectodermal stem cell clone. J. Neurosci. Res. 76 (2004) 801-811
10. Jelitai M., Anděrová M., Chvatal A., and Madarasz E. Electrophysiological characterization of neural stem/progenitor cells during in vitro differentiation: a study on an immortalized neuroectodermal cell line. J. Neurosci. Res. 85 (2007) 1606-1617
11. Joseph-Liauzun E., Farges R., Delmas P., Ferrara P., and Loison G. The Mr 18,000 subunit of the peripheral-type benzodiazepine receptor exhibits both benzodiazepine and isoquinoline carboxamide binding sites in the absence of the voltage-dependent anion channel or of the adenine nucleotide carrier. J. Biol. Chem. 272 (1997) 28102-28106
12. Kugler W., Veenman L., Shandalov Y., Leschiner S., Spanier I., Lakomek M., and Gavish M. Ligands of the mitochondrial 18 kDa translocator protein attenuate apoptosis of human glioblastoma cells exposed to erucylphosphohomocholine. Cell Oncol. 30 (2008) 435-450
13. Lacapere J.J., and Papadopoulos V. Peripheral-type benzodiazepine receptor: structure and function of a cholesterol binding protein in steroid and bile acid synthesis. Steroids 68 (2003) 569-585
14. Madarász E., Kiss J., and Bartók I. Cell production and morphological pattern formation in primary brain cell cultures. Brain Res. 304 (1984) 339-349
15. Madarász E., Theodosis D.T., and Poulain D.A. In vitro formation of type 2 astrocytes derived from postnatal rat hypothalamus or cerebral cortex. Neuroscience 43 (1991) 211-221
16. Mills C., Bitler J.D., and Woolf C.J. Role of the peripheral benzodiazepine receptor in sensory neuron regeneration. Mol. Cell. Neurosci. 30 (2005) 228-237
17. Mills C., Makwana M., Wallace A., Benn S., Schmidt H., Tegeder I., Costigan M., Brown Jr. R.H., Raivich G., and Woolf C.J. Ro5-4864 promotes neonatal motor neuron survival and nerve regeneration in adult rats. Eur. J. Neurosci. 27 (2008) 937-946
18. Morrow A.L. Recent developments in the significance and therapeutic relevance of neuroactive steroids. Pharmacol. Ther. 116 (2007) 1-6
19. Ostuni M.A., Ducroc R., Péranzi G., Tonon M.C., Papadopoulos V., and Lacapere J.J. Translocator protein (18 kDa) ligand PK 11195 induces transient mitochondrial Ca2+ release leading to transepithelial Cl-secretion in HT-29 human colon cancer cells. Biol. Cell 99 (2007) 639-647
20. Papadopoulos V., Baraldi M., Guilarte T.R., Knudsen T.B., Lacapére J.J., Lindemann P., Norenberg M.D., Nutt D., Weizman A., Zhang M.-R., and Gavish M. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 27 (2006) 402-409
21. Schlett K., and Madarász E. Retinoic acid induced neural differentiation in a neuroectodermal cell line immortalized by p53 deficiency. J. Neurosci. Res. 47 (1997) 405-415
22. Schlett K., Herberth B., and Madarasz E. In vitro pattern formation during neurogenesis by neuroectodermal progenitor cells immortalized by p53-deficiency. Int. J. Dev. Neurosci. 15 (1997) 795-804
23. Shoukrun R., Veenman L., Shandalov Y., Leschiner S., Spanier I., Karry R., Katz Y., Weisinger G., Weizman A., and Gavish M. The 18-kDa translocator protein, formerly known as the peripheral benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line. Pharmacogenet. Genom. 18 (2008) 977-988
24. Tárnok K., Pataki A., Kovács J., Schlett K., and Madarász E. Stage-dependent effects of cell-to-cell connections on the in vitro induced neurogenesis. Eur. J. Cell Biol. 81 (2002) 403-412
25. Varga B., Hádinger N., Gócza E., Dulberg V., Demeter K., Madarász E., and Herberth B. Generation of diverse neuronal subtypes in cloned populations of stem-like cells. BMC Dev. Biol. 8 (2008) 89-107
26. Venneti S., Lopresti B.J., and Wiley C.A. The peripheral benzodiazepine receptor (Translocator protein 18 kDa) in microglia: from pathology to imaging. Prog. Neurobiol. 80 (2006) 308-322
27. Veenman L., Papadopoulos V., and Gavish M. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr. Pharm. Des. 13 (2007) 2385-2405
28. Veenman L., Shandalov Y., and Gavish M. VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis. J. Bioenergy Biomembr. 40 (2008) 199-205
29. Weissman B.A., and Raveh L. Peripheral benzodiazepine receptors: on mice and human brain imaging. J. Neurochem. 84 (2003) 432-437
30. Zeno S., Zaaroor M., Leschiner S., Veenman L., and Gavish M. CoCl2 induces apoptosis via the 18 kDa translocator protein in U118MG human glioblastoma cells. Biochemistry (2009) 10.1021/bi900064t